J
John Cochran
My surgery was supposed to be today (4/24/02) but the right size valve is still not available. I guess I need a 23mm to 24 mm, and will be contacted when one becomes available for my planned Cryolife SynerGraft aortic valve replacement.
The following is from a Cryolife press release yesterday, updating the progress with SynerGraft implants (note that almost all are pulmonary valves, since they just started doing aortic valves this year). In the small number of valves that had to be removed, the good news is that they had all repopulated with the patient's own cells.
From the Cryolife press release:
SynerGraft Allograft Valves and Vascular Grafts Update
On the allograft side of the business, since February 2000, there have been 987 SynerGraft processed allograft heart valves implanted in people throughout North America. Of these valves, 982 remain implanted at this time. Five have been removed. Histological examination of some of these valves indicated that they did repopulate with the patient's own cells in vivo. Examinations also confirmed that the PRA (Panel Reactive Antibodies) levels were significantly reduced in the patients that were implanted with a SynerGraft processed allograft valve.
The following is from a Cryolife press release yesterday, updating the progress with SynerGraft implants (note that almost all are pulmonary valves, since they just started doing aortic valves this year). In the small number of valves that had to be removed, the good news is that they had all repopulated with the patient's own cells.
From the Cryolife press release:
SynerGraft Allograft Valves and Vascular Grafts Update
On the allograft side of the business, since February 2000, there have been 987 SynerGraft processed allograft heart valves implanted in people throughout North America. Of these valves, 982 remain implanted at this time. Five have been removed. Histological examination of some of these valves indicated that they did repopulate with the patient's own cells in vivo. Examinations also confirmed that the PRA (Panel Reactive Antibodies) levels were significantly reduced in the patients that were implanted with a SynerGraft processed allograft valve.